Insider Shareholders with Direct Ownership of Candel Therapeutics, Inc. (CADL)
This section provides a comprehensive overview of the insiders with direct ownership of Candel Therapeutics, Inc. (CADL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Candel Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Laura K. Aguilar
> 10% Shareholder |
227,431 | 68,534 | 1,033,840 $4.73 Million | 3 |
May 06, 2022
Reduced 6.22%
|
|
Estuardo Aguilar Cordova
> 10% Shareholder |
303,534 | 197,703 | 888,532 $4.07 Million | 18 |
Oct 28, 2024
Reduced 1.3%
|
|
Paul Peter Tak
Chief Executive Officer |
429,899 | 86,264 | 343,635 $1.57 Million | 9 |
Nov 21, 2024
Added 3.62%
|
|
Jason Amello
Chief Financial Officer |
222,162 | 20,153 | 202,009 $925,201 | 5 |
Nov 28, 2023
Reduced 9.07%
|
|
Francesca Barone
Chief Scientific Officer |
204,905 | 46,444 | 159,961 $732,621 | 6 |
Jul 17, 2024
Reduced 8.07%
|
| 27,000 | 0 | 152,000 $696,160 | 2 |
Dec 09, 2022
Added 13.61%
|
|
|
Seshu Tyagarajan
Chief Technology Officer |
191,558 | 45,509 | 146,049 $668,904 | 7 |
Jul 17, 2024
Reduced 9.23%
|
|
William Garrett Nichols
Chief Medical Officer |
147,301 | 32,819 | 114,482 $524,327 | 5 |
Jul 17, 2024
Reduced 8.68%
|
| 0 | 18,781 | 62,520 $286,341 | 2 |
Jul 17, 2024
Reduced 13.65%
|
|
| 56,000 | 0 | 56,000 $256,480 | 2 |
Jul 29, 2021
Added 26.32%
|
|
| 38,032 | 0 | 38,032 $174,186 | 2 |
Dec 09, 2022
Added 47.94%
|
|
|
John J Canepa
Chief Financial Officer |
10,125 | 0 | 10,125 $46,372 | 1 |
Jul 29, 2021
Added 50.0%
|
| 10,000 | 0 | 10,000 $45,800 | 1 |
Jul 29, 2021
Added 50.0%
|
|
|
Nathan Caffo
Chief Business Officer |
6,000 | 0 | 6,000 $27,480 | 1 |
Jul 29, 2021
Added 50.0%
|